🕵️ Theravance Biopharma, Inc. ($TBPH)
SEC insider & ownership activity, last 12 months · CIK 1583107 · every row links its SEC filing
Over the last 12 months insiders sold $8.5M with no open-market buying against it. Samaha Eli sold $5.9M (Jun–Jul). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 3 sellers, $8.5M (19 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Samaha Eli | 0 | – | 5 | $5.9M | Jul 7, 2026 |
| Broshy Eran | 0 | – | 5 | $1.4M | Nov 26, 2025 |
| Rhonda Farnum | 0 | – | 9 | $1.2M | Jun 15, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Weiss Asset Management LP | 14.5% | 13D | Mar 23, 2026 | filing ↗ | |
| WAM GP LLC | 14.5% | 13D | Mar 23, 2026 | filing ↗ | |
| Andrew M. Weiss | 14.5% | 13D | Mar 23, 2026 | filing ↗ | |
| BIP GP LLC | 9.0% | 13D | Mar 23, 2026 | filing ↗ | |
| Newtyn Management, LLC | 8.5% | 13G | Feb 17, 2026 | filing ↗ | |
| Blackrock, Inc. | 6.5% | 13G | Apr 30, 2025 | filing ↗ | |
| Newtyn TE Partners, LP | 5.3% | 13G | Feb 17, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Rhonda Farnum | $218K | Jun 15, 2026 | filing ↗ |
| Rhonda Farnum | $434K | Mar 16, 2026 | filing ↗ |
| Rhonda Farnum | $583K | Dec 3, 2025 | filing ↗ |
| Eran Broshy | $590K | Nov 26, 2025 | filing ↗ |
| Eran Broshy | $809K | Nov 11, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Jun 28, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 28, 2026 | filing ↗ |
| Other events (8.01) | Jun 28, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 28, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 19, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 12, 2026 | filing ↗ |
| Earnings (2.02) | May 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 7, 2026 | filing ↗ |
| Other events (8.01) | Mar 27, 2026 | filing ↗ |
| Earnings (2.02) | Mar 19, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 19, 2026 | filing ↗ |
| Earnings (2.02) | Mar 3, 2026 | filing ↗ |
| Exit or disposal costs (2.05) | Mar 3, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 3, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 12, 2026 | filing ↗ |
| Other events (8.01) | Dec 8, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 8, 2025 | filing ↗ |
| Earnings (2.02) | Nov 10, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 10, 2025 | filing ↗ |
| Other events (8.01) | Aug 25, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 25, 2025 | filing ↗ |
| Other events (8.01) | Aug 15, 2025 | filing ↗ |
| Earnings (2.02) | Aug 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 12, 2025 | filing ↗ |